Try a new search

Format these results:

Searched for:

person:liuw01

in-biosketch:true

Total Results:

3


Bioadhesive polymer semiconductors and transistors for intimate biointerfaces

Li, Nan; Li, Yang; Cheng, Zhe; Liu, Youdi; Dai, Yahao; Kang, Seounghun; Li, Songsong; Shan, Naisong; Wai, Shinya; Ziaja, Aidan; Wang, Yunfei; Strzalka, Joseph; Liu, Wei; Zhang, Cheng; Gu, Xiaodan; Hubbell, Jeffrey A; Tian, Bozhi; Wang, Sihong
The use of bioelectronic devices relies on direct contact with soft biotissues. For transistor-type bioelectronic devices, the semiconductors that need to have direct interfacing with biotissues for effective signal transduction do not adhere well with wet tissues, thereby limiting the stability and conformability at the interface. We report a bioadhesive polymer semiconductor through a double-network structure formed by a bioadhesive brush polymer and a redox-active semiconducting polymer. The resulting semiconducting film can form rapid and strong adhesion with wet tissue surfaces together with high charge-carrier mobility of ~1 square centimeter per volt per second, high stretchability, and good biocompatibility. Further fabrication of a fully bioadhesive transistor sensor enabled us to produce high-quality and stable electrophysiological recordings on an isolated rat heart and in vivo rat muscles.
PMCID:10768720
PMID: 37561870
ISSN: 1095-9203
CID: 5795412

Levetiracetam Pharmacokinetics and Brain Uptake in a Lateral Fluid Percussion Injury Rat Model

Coles, Lisa D; Saletti, Patricia G; Lisgaras, Christos Panagiotis; Casillas-Espinosa, Pablo M; Liu, Wei; Li, Qianyun; Jones, Nigel C; Shultz, Sandy; Ali, Idrish; Brady, Rhys; Yamakawa, Glenn; Hudson, Matt; Silva, Juliana; Braine, Emma; Mishra, Usha; Cloyd, James C; O'Brien, Terence J; Moshé, Solomon L; Galanopoulou, Aristea S; ,
Post-traumatic epilepsy (PTE) occurs in some patients after moderate/severe traumatic brain injury (TBI). Although there are no approved therapies to prevent epileptogenesis, levetiracetam (LEV) is commonly given for seizure prophylaxis due to its good safety profile. This led us to study LEV as part of the Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Project. The objective of this work is to characterize the pharmacokinetics (PK) and brain uptake of LEV in naïve control rats and in the lateral fluid percussion injury (LFPI) rat model of TBI after either single intraperitoneal doses or a loading dose followed by a 7-day subcutaneous infusion. Sprague-Dawley rats were used as controls and for the LFPI model induced at the left parietal region using injury parameters optimized for moderate/severe TBI. Naïve and LFPI rats received either a bolus injection (intraperitoneal) or a bolus injection followed by subcutaneous infusion over 7 days. Blood and parietal cortical samples were collected at specified time points throughout the study. LEV concentrations in plasma and brain were measured using validated high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) methods. Noncompartmental analysis and a naive-pooled compartmental PK modeling approach were used. Brain-to-plasma ratios ranged from 0.54 to 1.4 to 1. LEV concentrations were well fit by one-compartment, first-order absorption PK models with a clearance of 112 ml/h per kg and volume of distribution of 293 ml/kg. The single-dose pharmacokinetic data were used to guide dose selection for the longer-term studies, and target drug exposures were confirmed. Obtaining LEV PK information early in the screening phase allowed us to guide optimal treatment protocols in EpiBioS4Rx. SIGNIFICANCE STATEMENT: The characterization of levetiracetam pharmacokinetics and brain uptake in an animal model of post-traumatic epilepsy is essential to identify target concentrations and guide optimal treatment for future studies.
PMCID:10353071
PMID: 37316328
ISSN: 1521-0103
CID: 5806722

Achieving tissue-level softness on stretchable electronics through a generalizable soft interlayer design

Li, Yang; Li, Nan; Liu, Wei; Prominski, Aleksander; Kang, Seounghun; Dai, Yahao; Liu, Youdi; Hu, Huawei; Wai, Shinya; Dai, Shilei; Cheng, Zhe; Su, Qi; Cheng, Ping; Wei, Chen; Jin, Lihua; Hubbell, Jeffrey A; Tian, Bozhi; Wang, Sihong
Soft and stretchable electronics have emerged as highly promising tools for biomedical diagnosis and biological studies, as they interface intimately with the human body and other biological systems. Most stretchable electronic materials and devices, however, still have Young's moduli orders of magnitude higher than soft bio-tissues, which limit their conformability and long-term biocompatibility. Here, we present a design strategy of soft interlayer for allowing the use of existing stretchable materials of relatively high moduli to versatilely realize stretchable devices with ultralow tissue-level moduli. We have demonstrated stretchable transistor arrays and active-matrix circuits with moduli below 10 kPa-over two orders of magnitude lower than the current state of the art. Benefiting from the increased conformability to irregular and dynamic surfaces, the ultrasoft device created with the soft interlayer design realizes electrophysiological recording on an isolated heart with high adaptability, spatial stability, and minimal influence on ventricle pressure. In vivo biocompatibility tests also demonstrate the benefit of suppressing foreign-body responses for long-term implantation. With its general applicability to diverse materials and devices, this soft-interlayer design overcomes the material-level limitation for imparting tissue-level softness to a variety of bioelectronic devices.
PMCID:10372055
PMID: 37495580
ISSN: 2041-1723
CID: 5795402